Merck Raises $8 Billion in Multi-Tranche Notes Offering
Merck & Co., Inc. has raised $8 billion through a multi-tranche notes offering, including various debt instruments with maturities ranging from 2029 to 2065. The offering closed on December 4, 2025, under the company's shelf registration statement filed with the SEC. This capital raising effort involves several series of notes with varying interest rates and maturities.
Merck & Co., Inc. has closed an underwritten public offering of multiple series of notes, raising significant capital through various debt instruments. The offerings include $500 million of Floating Rate Notes due 2029, $750 million of 3.850% Notes due 2029, $1 billion of 4.150% Notes due 2031, $1 billion of 4.450% Notes due 2032, $1.5 billion of 4.750% Notes due 2035, $750 million of 5.500% Notes due 2046, $1.5 billion of 5.550% Notes due 2055, and $1 billion of 5.700% Notes due 2065. These notes were issued under the company’s shelf registration statement filed with the SEC. The offering closed on December 4, 2025. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Merck & Co. Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-25-055388), on December 04, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here
